OSR Health (OSRHW) Payables (2021 - 2026)
OSR Health (OSRHW) posted Payables of $10.6 million for Q1 2026, up 2.67% sequentially from $10.4 million in Q4 2025, and up 18.9% YoY from $8.9 million in Q1 2025.
OSR Health (OSRHW) Payables (2021 - 2026) Analysis & Trends
OSR Health has reported Payables for 6 years, with the latest figure at $10.6 million in Q1 2026.
- Quarterly Payables rose 18.9% year-over-year to $10.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $10.6 million (up 18.9% YoY) and the FY2025 annual result came in at $10.4 million, up 259.91% from the prior year.
- Payables climbed to $10.6 million in Q1 2026 per OSRHW's latest filing, from $10.4 million in the prior quarter.
- Over five years, Payables peaked at $10.6 million in Q1 2026 and troughed at $266485.0 in Q2 2023.
- A 5-year average of $4.5 million and a median of $2.7 million in 2024 frame the typical range for Payables.
- The sharpest annual moves came in 2023 and 2024: Payables fell 12.34% in 2023, then soared 857.04% in 2024.
- Over 5 years, Payables stood at $1.2 million in 2022, then fell by 12.34% to $1.1 million in 2023, then jumped by 166.1% to $2.9 million in 2024, then jumped by 259.91% to $10.4 million in 2025, then grew by 2.67% to $10.6 million in 2026.
- According to Business Quant data, Payables over the past three periods registered $10.6 million, $10.4 million, and $9.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.97 Bn | 131.12 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.15 Bn | 77.15 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 62.84 Bn | 57.65 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 55.74 Bn | 50.60 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.53 Bn | 36.43 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.60 Bn | 28.29 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 27.32 Bn | 8.93 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | 35.57 Mn |
| 9 | Insmed | 26.99 Bn | 25.83 Bn | 358.27 Mn | 428.93 Mn |
| 10 | OSR Health | 1.40 Mn | 20.39 Mn | 86,605.00 | 10.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.64 Mn |
| Dec 31, 2025 | 10.36 Mn |
| Sep 30, 2025 | 9.52 Mn |
| Jun 30, 2025 | 9.33 Mn |
| Mar 31, 2025 | 8.95 Mn |
| Dec 31, 2024 | 2.88 Mn |
| Sep 30, 2024 | 3.04 Mn |
| Jun 30, 2024 | 2.55 Mn |
| Mar 31, 2024 | 1.68 Mn |
| Dec 31, 2023 | 1.08 Mn |
| Sep 30, 2023 | 700,354.00 |
| Jun 30, 2023 | 266,485.00 |
| Mar 31, 2023 | 386,432.00 |
| Dec 31, 2022 | 1.23 Mn |
| Dec 31, 2021 | 402,847.00 |